Literature DB >> 6534480

Stamey endoscopic bladder neck suspension for stress incontinence.

M H Ashken, P H Abrams, W T Lawrence.   

Abstract

Sixty female patients with clinically demonstrable stress incontinence of urine have had a Stamey operation during the last 3 years. The results have been good in curing stress incontinence, whilst the majority of the failures have been in patients with severe detrusor instability or a chronic cough. There have been few post-operative complications and urodynamic studies have shown improved cough urethral profiles and no evidence of bladder outflow obstruction. The Stamey procedure can be recommended as the initial operation for surgically curable incontinence. Mild bladder instability is not a contraindication to the operation and it is also useful in elderly, unfit or obese patients.

Entities:  

Mesh:

Year:  1984        PMID: 6534480     DOI: 10.1111/j.1464-410x.1984.tb06133.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

1.  Needle suspension of the bladder neck for stress urinary incontinence: objective results at 11 to 16 years.

Authors:  Franz Moser; Vesna Bjelic-Radisic; Karl Tamussino
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-31

2.  Stamey endoscopic vesical neck suspension in female urinary stress incontinence: results and changes in various urodynamic parameters.

Authors:  A Athanassopoulos; M D Melekos; M Speakman; P Perimenis; S Markou; G A Barbalias
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

3.  Transvaginal colposuspension for the treatment of genuine stress incontinence combined with vaginal hysterectomy: a preliminary report.

Authors:  P Barlas; J Hatzipapas; A Bias; A Athanasopoulos
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

4.  Endoscopic transvaginal bladder neck suspension for stress urinary incontinence.

Authors:  A Erol; S Y Sargin; I Dalva; Z E Günes; E Akbay; A H Yazicioğlu
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.